“mpm-capital” Archives

in
Entry Author Date Location
Gilead Sciences Splashes Out $300M for Tizona Stake & Option to Acquire 07/21/20 San Francisco
Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline 06/04/20 Boston
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO 05/29/20 Boston
With $80M, ReCode Looks to Advance RNA Therapies for Lung Diseases 03/26/20 San Francisco
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Coda Bio Acquires Drug Candidates to Pair With Engineered Receptors 02/06/20 San Francisco
BioIntervene Raises $30M to Move Nerve Pain Drug Into the Clinic 01/07/20 San Diego
Triplet Therapeutics Unveils $59M to Try Hairpin Fix for Huntington’s 12/17/19 Boston
The Winners of the 2019 Xconomy Awards Boston Are… 09/12/19 Boston
Vertex Bets $950M on Semma and a Stem Cell Therapy for Diabetes 09/03/19 Boston
Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing 08/21/19 Boston
The Finalists for the 2019 Xconomy Awards Are … 07/10/19 Boston
ElevateBio Gets $150M to Grow a Crop of Gene & Cell Therapy Startups 05/13/19 Boston
Dyne Therapeutics Emerges With $50M to Take On Rare Muscle Disease 04/03/19 Boston
Clinical Analytics Platform TriNetX Raises $40M to Speed Drug Trials 03/13/19 Boston
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
Entrada Therapeutics Nabs $59M for Drugs that Gain “Entry” to Cells 12/18/18 Boston
Harvard Spinout 28-7 Launches with $65M for MicroRNA Cancer Drugs 09/06/18 Boston
Cullinan Oncology Emerges with $150M to Build Cancer Drug Portfolio 10/03/17 Boston
Not Resting on Hemophilia Biz, Bioverativ Pays $400M For True North 05/23/17 Boston
Bristol Flips Remnants of Adnexus, iPierian to Roche, Biogen For $470M 04/13/17 New York
Rhythm Raises $41M to Bankroll Late-Stage Push For Obesity Drug 02/16/17 Boston
Takeda, Maverick Therapeutics Enter $125M Cancer Therapy Partnership 01/11/17 San Francisco
TCR2 Therapeutics Unveils New Cancer Therapy Approach and $44.5M Round 12/08/16 Boston
Iconic Therapeutics Lands $10,000,000 Series C Financing 08/10/16 San Francisco
Oncorus Lands $57,000,000 Series A Financing Round 07/20/16 Boston
Oncorus Bags $57M, Touts Next-Gen Take on Cancer-Fighting Viruses 07/19/16 Boston
Blade Therapeutics Garners $45,000,000 Series B Funding 06/20/16 San Francisco
Harpoon Therapeutics Garners $15,000,000 New Financing 03/31/16 San Francisco
Tizona Therapeutics Obtains $43,000,000 Series B Funding 03/08/16 San Francisco
Page 1 of 9 next page »